Metastaserende renalcellecarcinom (mRCC) SUTENT er indiceret til behandling af avanceret og/ eller metastaserende renalcellecarcinom (mRCC).
Metastatic Renal Cell Carcinoma (MRCC) SUTENT is indicated for the treatment of advanced and/ or metastatic renal cell carcinoma (MRCC).